Self-monitoring Blood Glucose Devices Market, By Product Type (Self-Monitoring Blood Glucose (SMBG) Meters, Test Strips, Lancets, and Continuous Glucose Monitors), By Technology, By Testing Site, By Patient Type, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4144
|
Published Date
July 2025
|
Pages
284
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Self-monitoring Blood Glucose Devices Market size was valued at US$ 19,752.01 Million in 2024, expanding at a CAGR of 11.53% from 2025 to 2032.
The Self-Monitoring Blood Glucose Devices Market encompasses portable devices that allow individuals to independently measure their blood glucose levels, playing a vital role in managing diabetes worldwide. With over 422 million people affected by diabetes globally, according to the World Health Organization, the demand for these devices continues to rise alongside increasing awareness of self-care practices. However, high costs of advanced monitoring systems and limited accessibility in low-income regions pose significant challenges to widespread adoption. Technological innovations such as continuous glucose monitoring (CGM) integration, non-invasive sensors, and smartphone connectivity are creating new opportunities by enhancing user convenience and measurement accuracy. Furthermore, growing government initiatives aimed at promoting diabetes screening and management are driving greater market penetration, particularly in developing countries where early diagnosis and consistent monitoring can substantially improve patient outcomes.
Self-monitoring Blood Glucose Devices Market- Market Dynamics
Rising Diabetes Prevalence and Technological Innovations to Drive Demand for Self-Monitoring Glucose Devices
Rising diabetes prevalence combined with rapid technological advancements is driving the increased adoption of self-monitoring blood glucose devices worldwide. According to the International Diabetes Federation, about 1 in 10 adults globally lives with diabetes, highlighting the critical need for effective self-care solutions. Innovations such as non-invasive sensors and seamless mobile app integration are enhancing the convenience and accuracy of glucose monitoring. The U.S. Centers for Disease Control and Prevention (CDC) underscores that regular blood glucose monitoring can significantly reduce complications and improve the quality of life for people with diabetes. Additionally, government health initiatives in countries like India and Brazil are expanding access to these devices through subsidies and awareness programs, enabling millions to better manage their condition while easing the strain on healthcare systems. Globally, governments are increasingly prioritizing diabetes care, with the World Health Organization estimating that over 110 countries have adopted national diabetes strategies to improve prevention, diagnosis, and treatment, further fueling demand for self-monitoring technologies.
Self-monitoring Blood Glucose Devices Market- Key Insights
- According to our research analyst’s analysis, the global self-monitoring blood glucose devices market is projected to grow at a compound annual growth rate (CAGR) of approximately 11.53% between 2025 and 2032.
- In 2024, Self-Monitoring Blood Glucose (SMBG) meters are expected to hold the largest market share based on product type segmentation.
- Electrochemical technology led the market in 2024 within the technology segmentation.
- Fingertip testing was the dominant testing site segment in 2024.
- Among patient types, Type 2 diabetes represented the largest segment in 2024.
- Home care was the leading end-user segment in 2024.
- Regionally, North America generated the highest revenue in 2024.
Self-monitoring Blood Glucose Devices Market- Segmentation Analysis:
The Global Self-monitoring Blood Glucose Devices Market is segmented on the basis of Product Type, Technology, Testing Site, Patient Type, End User, and Region.
The blood glucose monitoring market is segmented into four key product types: Self-Monitoring Blood Glucose (SMBG) Meters, Test Strips, Lancets, and Continuous Glucose Monitors (CGMs). SMBG meters provide users with convenient, digital readings of their blood glucose levels, making daily diabetes management more accessible and accurate. Test strips are essential for ensuring the precision of these readings, delivering quick and reliable results that guide patient decisions. Lancets play a crucial role in blood sampling by minimizing discomfort during finger pricks, which enhances user compliance. Meanwhile, Continuous Glucose Monitors represent a growing segment due to their ability to provide real-time glucose tracking, allowing for more proactive and effective diabetes management. According to the U.S. Centers for Disease Control and Prevention (CDC), the increasing prevalence of diabetes—affecting over 37 million Americans—has prompted government initiatives to improve access to advanced glucose monitoring technologies, including subsidies for CGMs to improve patient outcomes.
In terms of technology, the market is primarily divided between Electrochemical and Photometric methods. Electrochemical technology leads the market due to its high precision, portability, and cost-effectiveness, making it the preferred choice for most SMBG devices worldwide. This technology’s ability to produce quick and accurate readings has made it the standard for personal and clinical glucose monitoring. On the other hand, photometric technology, while less common today, is still valued for its clear visual outputs and ease of interpretation, often used in older models and certain specialized clinical applications. The European Medicines Agency (EMA) has emphasized the importance of rigorous technology validation in glucose monitoring devices, leading to enhanced regulatory support for electrochemical systems due to their demonstrated reliability and accuracy in managing diabetes care.
Self-monitoring Blood Glucose Devices Market- Competitive Landscape:
The Self-Monitoring Blood Glucose (SMBG) Devices Market is highly competitive, featuring a mix of established industry leaders and emerging innovators. Key players such as Abbott Laboratories, Dexcom, Roche Diagnostics, LifeScan, and Ascensia Diabetes Care dominate the market with their advanced technologies and extensive global distribution networks. Abbott’s FreeStyle Libre series has transformed glucose monitoring with its innovative sensor technology and affordability, while Dexcom’s G6 and G7 systems are celebrated for their accuracy and user-friendly design. Roche’s Accu-Chek line remains a trusted choice, emphasizing reliability and seamless integration with digital health platforms. LifeScan’s OneTouch products focus on simplicity and precision, catering to a wide range of users, and Ascensia’s Contour series is recognized for its dependable performance and ease of use. The market is also welcoming new entrants like Ultrahuman, whose Ultrahuman M1 continuous glucose monitor targets athletes and health-conscious consumers. Strategic partnerships, ongoing technological advancements, and a strong emphasis on user-centric designs continue to drive innovation and competition within the SMBG devices market.
Recent Developments:
- In July 2024, Roche received the CE Mark for its Accu-Chek SmartGuide® continuous glucose monitoring (CGM) device, designed for adults with type 1 and type 2 diabetes. The device offers real-time glucose monitoring combined with AI-powered predictive alerts to enhance self-management.
- In May 2024, Intuity Medical and embecta announced a commercial collaboration to expand access to Intuity’s POGO Automatic® Blood Glucose Monitoring System, aiming to improve self-monitoring options and diabetes care across the United States.
- In April 2023, Astellas and Roche Diabetes Care Japan partnered to develop and commercialize an integrated diabetes self-management solution, combining Roche’s blood glucose monitoring devices with the BlueStar digital health platform to advance diabetes care in Japan.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Abbott Laboratories
- Acon Laboratories, Inc.
- ARKRAY, Inc.
- Ascensia Diabetes Care
- B. Braun Melsungen AG
- Bayer AG
- Dexcom, Inc.
- Eli Lilly and Company
- GlucoMe
- i-SENS, Inc.
- LifeScan, Inc.
- Medtronic plc
- Nipro Corporation
- Nova Biomedical
- PHC Holdings Corporation
- Roche Diagnostics
- Sanofi
- Terumo Corporation
- Trividia Health, Inc.
- Ypsomed Holding AG
GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
- Self-Monitoring Blood Glucose (SMBG) Meters
- Test Strips
- Lancets
- Continuous Glucose Monitors
GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032
- Electrochemical
- Photometric
GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY TESTING SITE- MARKET ANALYSIS, 2019 - 2032
- Fingertip
- Alternate Site Testing
GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PATIENT TYPE- MARKET ANALYSIS, 2019 - 2032
- Type 1 Diabetes
- Type 2 Diabetes
- Gestational Diabetes
GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals
- Ambulatory Surgery Centers
- Diagnostics Center
- Home Care
- Other
GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Self-monitoring Blood Glucose Devices Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Self-monitoring Blood Glucose Devices Market Snippet by Product Type
2.1.2. Self-monitoring Blood Glucose Devices Market Snippet by Technology
2.1.3. Self-monitoring Blood Glucose Devices Market Snippet by Testing Site
2.1.4. Self-monitoring Blood Glucose Devices Market Snippet by Patient Type
2.1.5. Self-monitoring Blood Glucose Devices Market Snippet by End User
2.1.6. Self-monitoring Blood Glucose Devices Market Snippet by Country
2.1.7. Self-monitoring Blood Glucose Devices Market Snippet by Region
2.2. Competitive Insights
3. Self-monitoring Blood Glucose Devices Key Market Trends
3.1. Self-monitoring Blood Glucose Devices Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Self-monitoring Blood Glucose Devices Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Self-monitoring Blood Glucose Devices Market Opportunities
3.4. Self-monitoring Blood Glucose Devices Market Future Trends
4. Self-monitoring Blood Glucose Devices Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Self-monitoring Blood Glucose Devices Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Self-monitoring Blood Glucose Devices Market Landscape
6.1. Self-monitoring Blood Glucose Devices Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Self-monitoring Blood Glucose Devices Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
7.1.2. Self-Monitoring Blood Glucose (SMBG) Meters
7.1.3. Test Strips
7.1.4. Lancets
7.1.5. Continuous Glucose Monitors
8. Self-monitoring Blood Glucose Devices Market – By Technology
8.1. Overview
8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
8.1.2. Electrochemical
8.1.3. Photometric
9. Self-monitoring Blood Glucose Devices Market – By Testing Site
9.1. Overview
9.1.1. Segment Share Analysis, By Testing Site, 2024 & 2032 (%)
9.1.2. Fingertip
9.1.3. Alternate Site Testing
10. Self-monitoring Blood Glucose Devices Market – By Patient Type
10.1. Overview
10.1.1. Segment Share Analysis, By Patient Type, 2024 & 2032 (%)
10.1.2. Type 1 Diabetes
10.1.3. Type 2 Diabetes
10.1.4. Gestational Diabetes
11. Self-monitoring Blood Glucose Devices Market – By End User
11.1. Overview
11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
11.1.2. Hospitals
11.1.3. Ambulatory Surgery Centers
11.1.4. Diagnostics Center
11.1.5. Home Care
11.1.6. Other
12. Self-monitoring Blood Glucose Devices Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
12.2. North America
12.2.1. Overview
12.2.2. Self-monitoring Blood Glucose Devices Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.6. North America Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
12.2.7. North America Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Self-monitoring Blood Glucose Devices Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.10. UK
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.10.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.10.5. UK Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
12.3.10.6. UK Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.11. France
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.11.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.11.5. France Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
12.3.11.6. France Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.12. Italy
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.12.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.12.5. Italy Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
12.3.12.6. Italy Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.13. Spain
12.3.13.1. Overview
12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.13.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.13.5. Spain Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
12.3.13.6. Spain Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.14. The Netherlands
12.3.14.1. Overview
12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.14.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.14.5. The Netherlands Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
12.3.14.6. The Netherlands Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.15. Sweden
12.3.15.1. Overview
12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.16. Russia
12.3.16.1. Overview
12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.16.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.16.5. Russia Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
12.3.16.6. Russia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.17. Poland
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.17.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.17.5. Poland Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
12.3.17.6. Poland Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.18. Rest of Europe
12.3.18.1. Overview
12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.18.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.18.5. Rest of the Europe Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
12.3.18.6. Rest of the Europe Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Self-monitoring Blood Glucose Devices Key Manufacturers in Asia Pacific
12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.6. APAC Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
12.4.7. APAC Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.9. China
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.9.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.9.5. China Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
12.4.9.6. China Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.10. India
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.10.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.10.5. India Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
12.4.10.6. India Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.14. Indonesia
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.14.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.14.5. Indonesia Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
12.4.14.6. Indonesia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.15. Thailand
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.15.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.15.5. Thailand Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
12.4.15.6. Thailand Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.17. Rest of APAC
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.17.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.17.5. Rest of APAC Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
12.4.17.6. Rest of APAC Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5. Latin America (LATAM)
12.5.1. Overview
12.5.2. Self-monitoring Blood Glucose Devices Key Manufacturers in Latin America
12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.6. LATAM Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
12.5.7. LATAM Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Self-monitoring Blood Glucose Devices Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.15. Rest of MEA
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.15.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.15.5. Rest of MEA Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
12.6.15.6. Rest of MEA Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13. Key Vendor Analysis- Self-monitoring Blood Glucose Devices Industry
13.1. Competitive Dashboard
13.1.1. Competitive Benchmarking
13.1.2. Competitive Positioning
13.2. Company Profiles
13.2.1. Abbott Laboratories
13.2.2. Acon Laboratories, Inc.
13.2.3. ARKRAY, Inc.
13.2.4. Ascensia Diabetes Care
13.2.5. B. Braun Melsungen AG
13.2.6. Bayer AG
13.2.7. Dexcom, Inc.
13.2.8. Eli Lilly and Company
13.2.9. GlucoMe
13.2.10. i-SENS, Inc.
13.2.11. LifeScan, Inc.
13.2.12. Medtronic plc
13.2.13. Nipro Corporation
13.2.14. Nova Biomedical
13.2.15. PHC Holdings Corporation
13.2.16. Roche Diagnostics
13.2.17. Sanofi
13.2.18. Terumo Corporation
13.2.19. Trividia Health, Inc.
13.2.20. Ypsomed Holding AG
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS